These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36307392)

  • 1. Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis.
    Susai SR; Healy C; Mongan D; Heurich M; Byrne JF; Cannon M; Cagney G; Wynne K; Markulev C; Schäfer MR; Berger M; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Street R; Thompson A; Yung AR; Nelson B; McGorry PD; Föcking M; Amminger GP; Cotter D
    Transl Psychiatry; 2022 Oct; 12(1):454. PubMed ID: 36307392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial.
    Susai SR; Mongan D; Healy C; Cannon M; Nelson B; Markulev C; Schäfer MR; Berger M; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; McGorry PD; Föcking M; Cotter D; Amminger GP
    Brain Behav Immun; 2022 Jan; 99():147-156. PubMed ID: 34624483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning based prediction and the influence of complement - Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial.
    Susai SR; Mongan D; Healy C; Cannon M; Cagney G; Wynne K; Byrne JF; Markulev C; Schäfer MR; Berger M; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Street R; Thompson A; Ruth Yung A; Nelson B; McGorry PD; Föcking M; Paul Amminger G; Cotter D
    Brain Behav Immun; 2022 Jul; 103():50-60. PubMed ID: 35341915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.
    Smesny S; Milleit B; Hipler UC; Milleit C; Schäfer MR; Klier CM; Holub M; Holzer I; Berger GE; Otto M; Nenadic I; Berk M; McGorry PD; Sauer H; Amminger GP
    Mol Psychiatry; 2014 Mar; 19(3):317-24. PubMed ID: 23478748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
    Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
    Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.
    Amminger GP; Mechelli A; Rice S; Kim SW; Klier CM; McNamara RK; Berk M; McGorry PD; Schäfer MR
    Transl Psychiatry; 2015 Jan; 5(1):e495. PubMed ID: 25585167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.
    McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EY; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Amminger GP
    JAMA Psychiatry; 2017 Jan; 74(1):19-27. PubMed ID: 27893018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis.
    McLaverty A; Allott KA; Berger M; Hester R; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Amminger GP
    Early Interv Psychiatry; 2021 Aug; 15(4):874-881. PubMed ID: 32893462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study.
    Berger ME; Smesny S; Kim SW; Davey CG; Rice S; Sarnyai Z; Schlögelhofer M; Schäfer MR; Berk M; McGorry PD; Amminger GP
    Transl Psychiatry; 2017 Aug; 7(8):e1220. PubMed ID: 28850110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal investigation of the relationship between omega-3 polyunsaturated fatty acids and neuropsychological functioning in recent-onset psychosis: A randomized clinical trial.
    Szeszko PR; McNamara RK; Gallego JA; Malhotra AK; Govindarajulu U; Peters BD; Robinson DG
    Schizophr Res; 2021 Feb; 228():180-187. PubMed ID: 33444934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 fatty acids for the treatment of dementia.
    Burckhardt M; Herke M; Wustmann T; Watzke S; Langer G; Fink A
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009002. PubMed ID: 27063583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional and longitudinal associations of circulating omega-3 and omega-6 fatty acids with lipoprotein particle concentrations and sizes: population-based cohort study with 6-year follow-up.
    Mäntyselkä P; Niskanen L; Kautiainen H; Saltevo J; Würtz P; Soininen P; Kangas AJ; Ala-Korpela M; Vanhala M
    Lipids Health Dis; 2014 Feb; 13():28. PubMed ID: 24507090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?
    Föcking M; Dicker P; Lopez LM; Cannon M; Schäfer MR; McGorry PD; Smesny S; Cotter DR; Amminger GP
    BMC Psychiatry; 2016 Sep; 16(1):326. PubMed ID: 27650124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
    Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
    Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyunsaturated fatty acids in emerging psychosis.
    Mossaheb N; Schloegelhofer M; Schaefer MR; Fusar-Poli P; Smesny S; McGorry P; Berger G; Amminger GP
    Curr Pharm Des; 2012; 18(4):576-91. PubMed ID: 22239591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis.
    Amminger GP; Nelson B; Markulev C; Yuen HP; Schäfer MR; Berger M; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; McGorry PD
    Biol Psychiatry; 2020 Feb; 87(3):243-252. PubMed ID: 31690495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyunsaturated fatty acids in emerging psychosis: a safer alternative?
    Schlögelhofer M; Amminger GP; Schaefer MR; Fusar-Poli P; Smesny S; McGorry P; Berger G; Mossaheb N
    Early Interv Psychiatry; 2014 Aug; 8(3):199-208. PubMed ID: 24861004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma eicosapentaenoic acid is negatively associated with all-cause mortality among men and women in a population-based prospective study.
    Miura K; Hughes MCB; Ungerer JP; Green AC
    Nutr Res; 2016 Nov; 36(11):1202-1209. PubMed ID: 27865614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of n-3 polyunsaturated fatty acids and inflammatory indicators with renal function decline in type 2 diabetes.
    Chung HF; Long KZ; Hsu CC; Al Mamun A; Jhang HR; Shin SJ; Hwang SJ; Huang MC
    Clin Nutr; 2015 Apr; 34(2):229-34. PubMed ID: 24721145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between plasma free fatty acids, cognitive function and structural integrity of the brain in middle-aged healthy humans.
    Herrmann M; Simstich S; Fauler G; Hofer E; Fritz-Petrin E; Herrmann W; Schmidt R
    Aging (Albany NY); 2021 Sep; 13(18):22078-22091. PubMed ID: 34554925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.